[Federal Register Volume 75, Number 235 (Wednesday, December 8, 2010)]
[Notices]
[Pages 76474-76475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-30813]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Developing Implementation Packages for Evidenced-
based HIV Prevention Intervention Materials for Drug Users (5563).
    Date: December 14, 2010.
    Time: 9:30 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852. (Telephone Conference Call).
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1439. lf33c.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Rapid Portable Devices to Measure Drug Use (1206).
    Date: December 20, 2010.
    Time: 9:30 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852. (Telephone Conference Call).
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive

[[Page 76475]]

Boulevard, Bethesda, MD 20892-8401. (301) 435-1439. lf33c.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel N43DA-11-5564: Developing, Validating, Refining Tools 
for Ecologic Momentary Assessment.
    Date: January 6, 2011.
    Time: 10 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Kristen V. Huntley, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401. (301) 435-1433. [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Development of a Device for Auto-administering 
Naloxone to Overcome Overdose (2223).
    Date: January 7, 2011.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Minna Liang, PhD, Scientific Review Officer, 
Training and Special Projects Review Branch, Office of Extramural 
Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 
8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401. (301) 435-
1432. [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Confirming Compliance with Experimental 
Pharmacotherapy Treatment of Drug Abuse (2225).
    Date: January 11, 2011.
    Time: 9:30 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1439. lf33c.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel New Techniques for the Large Scale Production and 
Purification of Antibodies or Vaccines for the Treatment of 
Substance Use Disorders (8898).
    Date: January 11, 2011.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Minna Liang, PhD, Scientific Review Officer, 
Training and Special Projects Review Branch, Office of Extramural 
Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 
8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401. (301) 435-
1432. [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Tool Development for New or Improved Capture Reagents 
(7779).
    Date: January 11, 2011.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Jose F. Ruiz, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401. (301) 451-3086. [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Real-time Activity as a Potential Diagnostic Marker 
for Pain or Drug-craving (4413).
    Date: January 12, 2011.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Scott A. Chen, PhD, Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 
20892-8401. (301) 443-9511. [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Improving Measures of Addiction Risk (5562).
    Date: January 13, 2011.
    Time: 9:30 a.m. to 1:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1439. lf33c.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Development of a Device to Assess Hyperalgesia at the 
Bed Side by the Cold Pressor (2224).
    Date: January 13, 2011.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Scott A. Chen, PhD, Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 
20892-8401. (301) 443-9511. [email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: December 2, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-30813 Filed 12-7-10; 8:45 am]
BILLING CODE 4140-01-P